Onivyde: Medgend

Onivyde FDA Approved Drugs

CAMPTOSAR [Irinotecan Hydrochloride^{C₃₃H₃₈N₄O₆ClH3H₂O}]

100mg/5ml (20mg/ml) (injection injectable)

300mg/15ml (20mg/ml) (injection injectable)

40mg/2ml (20mg/ml) (injection injectable)

Pfizer Inc^{Jun 14, 1996}

Use in combination with 5-fluorouracil and leucovorin for the treatment of metastatic colorectal cancer where the dose of leucovorin is at least 200mg per square meter.
Use of irinotecan in combination with 5-fluorouracil and leucovorin for the treatment of metastatic colorectal cancer.

efficacy
5.0 (1)

side effects
0.0 (0)

danger
0.0 (0)

IRINOTECAN HYDROCHLORIDE [Irinotecan Hydrochloride^{C₃₃H₃₈N₄O₆ClH3H₂O}]

100mg/5ml (20mg/ml) (injection injectable)

300mg/15ml (20mg/ml) (injection injectable)

40mg/2ml (20mg/ml) (injection injectable)

500mg/25ml (20mg/ml) (injection injectable)

Accord Hlthcare^{Nov 21, 2008}
Actavis Totowa^{Feb 27, 2008}
Akorn^{Sep 16, 2009}
Cipla Ltd^{Feb 20, 2008}
Dr Reddys Labs Ltd^{Apr 15, 2010}
Emcure Pharms Ltd^{Feb 14, 2012}
Fresenius Kabi Oncol^{Feb 27, 2008}
Fresenius Kabi Usa^{Feb 27, 2008}
Hikma Farmaceutica^{Dec 20, 2010}
Hisun Pharm Hangzhou^{Jan 28, 2009}
Hospira^{Feb 27, 2008}
Ingenus Pharms Llc^{May 26, 2017}
Jiangsu Hengrui Med^{Dec 16, 2011}
Mustafa Nevzat Ilac^{May 13, 2011}
Pliva Lachema^{Oct 31, 2008}
Qilu Pharm Co Ltd^{May 3, 2016}
Sandoz Inc^{Nov 12, 2009}
Sun Pharma Global^{Apr 21, 2008}
Teva Pharms Usa^{Feb 27, 2008}
West-ward Pharms Int^{Dec 24, 2008}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

ONIVYDE [Irinotecan Hydrochloride^{C₃₃H₃₈N₄O₆ClH3H₂O}]

eq 43mg base/10ml (eq 4.3mg base/ml) (iv (infusion) injectable, liposomal)

Ipsen Inc^{Oct 22, 2015}

Treatment of exocrine pancreatic cancer that has progressed on gemcitabine-based therapy, in combination with 5-fluorouracil and leucovorin.
Treatment of metastatic adenocarcinoma of the pancreas that has progressed on gemcitabine-based therapy, in combination with 5-fluorouracil and leucovorin, in a patient homozygous for the ugt1a1*28 allele.
Treatment of metastatic adenocarcinoma of the pancreas that has progressed on gemcitabine-based therapy, in combination with 5-fluorouracil and leucovorin.
Treatment of pancreatic cancer that has progressed on gemcitabine-based therapy, in combination with 5-fluorouracil and leucovorin.
Treatment of pancreatic cancer.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.

Ledgend of Medicine

MODERN MEDICINES

HOME REMEDIES

RANDOM DRUGS

RANDOM AILMENTS

Onivyde FDA Approved Drugs